cbdMD Acquires Substantially All Assets of Bluebird Botanicals
January 29, 2026
cbdMD, Inc. (NYSE American: YCBD) acquired substantially all assets of Bluebird Botanicals in early January 2026 to integrate Bluebird's regulatory science, safety and IP assets into cbdMD's clinical and toxicology platform. The deal strengthens cbdMD's regulatory-compliance and GRAS capabilities for both broad-spectrum and full-spectrum cannabinoid formulations and is expected to contribute to revenue growth and expanded product safety dossiers.
- Buyers
- cbdMD, Inc.
- Targets
- Bluebird Botanicals
- Industry
- Consumer Products
- Location
- Colorado, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Bluebird Botanicals Acquires Precision Botanical; Juggernaut Capital Provides Growth Investment
July 23, 2021
Consumer Products
Bluebird Botanicals acquired Precision Botanical, gaining access to Precision’s Oregon-based hemp cultivation and extraction facility and science-driven product capabilities. Concurrently, Juggernaut Capital Partners made a growth investment in Bluebird to strengthen the combined company's financial profile and support online growth, retail expansion and product innovation.
-
Lucy Scientific Discovery Acquires BlueSky Wellness
September 12, 2023
Consumer Products
Lucy Scientific Discovery Inc. (NASDAQ: LSDI) agreed to acquire BlueSky Wellness Inc. in an all-stock transaction that will add a portfolio of plant-based wellness CPG brands (Keoni, Keoni Sport, Blush Wellness, AMMA Healing) and e-commerce capabilities. BlueSky shareholders will receive 3.5 million Lucy shares plus up-to-five-year EBITDA-based earnouts; Lucy expects the combined transactions with its High Times IP acquisition to add at least $30 million in revenue and $10 million of EBITDA in the first 12 months.
-
TerrAscend Acquires Hempaid, LLC (d/b/a Blue Ridge Wellness)
June 27, 2023
Retail
TerrAscend Corp. entered into a definitive agreement to acquire Hempaid, LLC (d/b/a Blue Ridge Wellness), a medical dispensary in Parkville, Maryland, for US$6.75 million (including US$3.0 million cash and a seller's note). The acquisition expands TerrAscend's Maryland retail footprint to three dispensaries ahead of the state's adult-use launch on July 1, 2023 and is expected to be immediately accretive to EBITDA and cash flow.
-
Carlyle and SK Capital Acquire bluebird bio
May 14, 2025
Biotechnology
Funds managed by The Carlyle Group and SK Capital Partners have completed a takeover of bluebird bio, taking the Somerville, Massachusetts-based gene therapy company private. The deal provides significant primary capital and a new management team led by David Meek to scale commercial delivery, expand manufacturing capacity, and stabilize bluebird's financial position following liquidity concerns.
-
OTC Markets Group Acquires Blue Sky Data Corp Assets
March 17, 2022
Data & Analytics
OTC Markets Group Inc. signed a definitive agreement to acquire the assets of Blue Sky Data Corp, a provider of state "Blue Sky" securities compliance data, with the transaction expected to close in early May 2022. The acquisition expands OTC Markets' Blue Sky data offering to enhance compliance tools for broker-dealers, financial advisors, public companies and regulators.
-
H.I.G. Capital Makes Equity Investment in The Bluebird Group
August 9, 2021
Marketing & Advertising
An affiliate of H.I.G. Capital has made an equity investment in The Bluebird Group, a Minneapolis-based retail services and consulting firm. The investment will support Bluebird's expansion and development of next-generation digital insights and analytics to enhance services for consumer brands.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.